BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 22, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
July 30, 2015
View Archived Issues
Drugs, Devices and More: The Foresite saga: Third capital fund gets $450M to carry strategy onward
Read More
Spectranetics enrolls study: Insider stock buys, enrollment give Spectranetics shares a modest bounce
Read More
Inside the Beltway: App association chief says fix health IT payment or face economic disaster
Read More
Financings: Bigfoot Biomedical raises $3.8 million
Read More
Agreements/contracts: Biodesix partners with Biognosys for HRM tech
Read More
Patent Watch: Luxcath awarded U.S. patent for tech visualizing ablated tissue
Read More
Products
Read More
Briefly noted
Read More
MDD's Orthopedics Extra
Read More
Edwards beats quarterly estimates: TAVR market growth propels Edwards'Q2 sales above analyst expectations
A booming transcatheter aortic valve replacement/implant market knocked quarterly sales out of the park for Edwards Lifesciences (NYSE: EW) (Irvine, Calif.).
Read More
Latin America: A battle lost, but war continues in PIP case against T V Rheinland
Read More
